HK Stock MarketDetailed Quotes
02279 YONGHE MEDICAL
- 0.750
- 0.0000.00%
Not Open Nov 22 16:08 CST
394.05MMarket Cap-783P/E (TTM)
0.750High0.730Low278.50KVolume0.740Open0.750Pre Close203.72KTurnover0.05%Turnover RatioLossP/E (Static)525.40MShares3.13052wk High0.45P/B394.05MFloat Cap0.60052wk Low--Dividend TTM525.40MShs Float18.907Historical High--Dividend LFY2.67%Amplitude0.600Historical Low0.731Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
YONGHE MEDICAL Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.75%900.2M | 25.80%1.78B | 10.65%827.81M | -34.85%1.41B | -28.98%748.14M | 32.37%2.17B | 75.11%1.05B | 33.80%1.64B | --601.56M | 31.05%1.22B |
| Operating income | 8.75%900.2M | 25.80%1.78B | 10.65%827.81M | -34.85%1.41B | -28.98%748.14M | 32.37%2.17B | 75.11%1.05B | 33.80%1.64B | 601.56M | 31.05%1.22B |
| Cost of sales | -2.93%-370.77M | -44.40%-780.07M | -34.59%-360.21M | 8.22%-540.21M | 3.72%-267.64M | -41.26%-588.6M | -67.45%-277.98M | -24.24%-416.67M | ---166.01M | -44.43%-335.38M |
| Operating expenses | -2.93%-370.77M | -44.40%-780.07M | -34.59%-360.21M | 8.22%-540.21M | 3.72%-267.64M | -41.26%-588.6M | -67.45%-277.98M | -24.24%-416.67M | -166.01M | -44.43%-335.38M |
| Gross profit | 13.22%529.44M | 14.28%997.19M | -2.68%467.6M | -44.77%872.58M | -38.03%480.5M | 29.33%1.58B | 78.03%775.42M | 37.40%1.22B | 435.55M | 26.63%889.1M |
| Selling expenses | 7.19%-462.57M | -36.20%-1.04B | -28.37%-498.4M | 28.51%-766.78M | 32.82%-388.25M | -37.59%-1.07B | -134.34%-577.95M | -19.89%-779.61M | ---246.63M | -40.24%-650.26M |
| Administrative expenses | 19.38%-140.97M | -45.35%-374.32M | -54.70%-174.86M | -4.03%-257.53M | -24.02%-113.03M | -52.78%-247.54M | -31.25%-91.14M | -24.67%-162.02M | ---69.44M | -38.33%-129.96M |
| Research and development expenses | 4.61%-12.43M | -58.31%-29.28M | -50.91%-13.03M | -30.59%-18.5M | -40.32%-8.63M | -19.87%-14.16M | -12.74%-6.15M | -33.22%-11.82M | ---5.46M | -13.60%-8.87M |
| Impairment and provision | 71.01%-80K | -86.23%-257K | -406.67%-276K | -190.20%-138K | 123.94%90K | 131.42%153K | -34.77%-376K | -1,332.35%-487K | ---279K | 97.92%-34K |
| -Other impairment is provision | 71.01%-80K | -86.23%-257K | -406.67%-276K | -190.20%-138K | 123.94%90K | 131.42%153K | -34.77%-376K | -1,332.35%-487K | ---279K | 97.92%-34K |
| Special items of operating profit | -614.21%-44.04M | -1,022.90%-80.71M | -204.46%-6.17M | -15.25%8.75M | -36.83%5.9M | 819.53%10.32M | 311.79%9.34M | 25.70%-1.43M | ---4.41M | 68.30%-1.93M |
| Operating profit | 41.97%-130.65M | -229.01%-531.75M | -861.24%-225.13M | -163.11%-161.62M | -121.46%-23.42M | -3.82%256.1M | -0.17%109.15M | 171.58%266.26M | 109.33M | -23.97%98.04M |
| Financing income | -27.19%5.52M | -87.71%12.7M | -88.13%7.59M | 1,586.49%103.38M | 2,553.45%63.9M | 551.43%6.13M | 1,004.59%2.41M | 348.10%941K | --218K | 51.08%210K |
| Financing cost | 44.52%-21.57M | -29.17%-66.17M | -42.95%-38.88M | 1.39%-51.23M | -19.94%-27.2M | -43.16%-51.95M | -41.68%-22.68M | -35.77%-36.29M | ---16.01M | -50.09%-26.73M |
| Earning before tax | 42.79%-146.7M | -434.61%-585.22M | -2,031.81%-256.43M | -152.06%-109.47M | -85.06%13.27M | -8.94%210.28M | -4.99%88.88M | 222.85%230.91M | 93.54M | -35.73%71.52M |
| Tax | -73.37%8.05M | 63.23%38.54M | 594.31%30.24M | 126.21%23.61M | 108.99%4.36M | -33.30%-90.09M | -72.47%-48.43M | -88.26%-67.58M | ---28.08M | 37.88%-35.9M |
| After-tax profit from continuing operations | 38.70%-138.65M | -536.73%-546.68M | -1,383.06%-226.19M | -171.44%-85.86M | -56.41%17.63M | -26.41%120.19M | -38.22%40.44M | 358.49%163.33M | 65.46M | -33.41%35.62M |
| Earning after tax | 38.70%-138.65M | -536.73%-546.68M | -1,383.06%-226.19M | -171.44%-85.86M | -56.41%17.63M | -26.41%120.19M | -38.22%40.44M | 358.49%163.33M | 65.46M | -33.41%35.62M |
| Minority profit | ---76K | ---290K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 38.74%-138.57M | -536.39%-546.39M | -1,383.06%-226.19M | -171.44%-85.86M | -56.41%17.63M | -26.41%120.19M | -38.22%40.44M | 358.49%163.33M | 65.46M | -33.41%35.62M |
| Basic earnings per share | 36.36%-0.28 | -575.00%-1.08 | -1,566.67%-0.44 | -155.17%-0.16 | -70.00%0.03 | -25.64%0.29 | -37.50%0.1 | 333.33%0.39 | 0.16 | -30.77%0.09 |
| Diluted earnings per share | 36.36%-0.28 | -575.00%-1.08 | -1,566.67%-0.44 | -157.14%-0.16 | -70.00%0.03 | -28.21%0.28 | -37.50%0.1 | 333.33%0.39 | 0.16 | -30.77%0.09 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data